kalpana panati
kalpana panati
Govt College for Men
Verified email at gcmkadapa.ac.in
Cited by
Cited by
Irisin/FNDC5–An updated review
K Panati, Y Suneetha, VR Narala
Eur Rev Med Pharmacol Sci 20 (4), 689-697, 2016
Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
VR Narala, MR Smith, RK Adapala, R Ranga, K Panati, BB Moore, T Leff, ...
Gene therapy & molecular biology 13 (1), 20, 2009
Curcumin nanotechnologies and its anticancer activity
PA Subramani, K Panati, VR Narala
Nutrition and cancer 69 (3), 381-393, 2017
Ovarian cancer biology and immunotherapy
TS Latha, K Panati, DSK Gowd, MC Reddy, D Lomada
International reviews of immunology 33 (5), 428-440, 2014
The role of nitrated fatty acids and peroxisome proliferator-activated receptor gamma in modulating inflammation
VR Narala, PA Subramani, VR Narasimha, FB Shaik, K Panati
International immunopharmacology 23 (1), 283-287, 2014
Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population
K Panati, S Pal, R KV, VD Reddy
Genes & genetic systems 87 (3), 191-196, 2012
Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the TH2 cytokines
FB Shaik, K Panati, VR Narasimha, VR Narala
Biochemical and biophysical research communications 463 (4), 600-605, 2015
COVID-19 outbreak: an update on therapeutic options
K Panati, VR Narala
SN comprehensive clinical medicine 2 (4), 379-380, 2020
Recombinant approach for the production of HIV fusion inhibitor Enfuvirtide using Escherichia coli
RR Kosana, C Bajji, RM Kanumuri, K Panati, LN Mangamoori, ...
Protein expression and purification 95, 136-142, 2014
Expression, purification and biological characterisation of recombinant human irisin (12.5 kDa)
K Panati, VR Narala, VR Narasimha, M Derangula, VRRA Tatireddigari, ...
Journal of Genetic Engineering and Biotechnology 16 (2), 459-466, 2018
Nanostructures for curcumin delivery: possibilities and challenges
PA Subramani, K Panati, VR Lebaka, DD Reddy, VR Narala
Nano-and Microscale Drug Delivery Systems, 393-418, 2017
Increased yield of high purity recombinant human brain natriuretic peptide by acid hydrolysis of short fusion partner in Escherichia coli
RM Kanumuri, C Bajji, RR Tummuru, VRRA Tatireddigari, ...
Protein expression and purification 111, 61-67, 2015
Changes in ATPase and phosphatases in different tissues of crab, Oziotelphusa senex senex, following exposure to fenvalerate
K Panati, VR Narala, VR Tatireddigari
The Bioscan 7 (3), 487-489, 2012
The nitrated fatty acid, 10-nitrooleate inhibits the neutrophil chemotaxis via peroxisome proliferator-activated receptor gamma in CLP-induced sepsis in mice
K Panati, PA Subramani, MM Reddy, M Derangula, VRRA Tatireddigari, ...
International immunopharmacology 72, 159-165, 2019
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene polymorphism in pulmonary tuberculosis in the Indian population
VR Narasimha, K Panati, MG Reddy, VR Narala
International journal of mycobacteriology 5 (3), 346-350, 2016
Gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor enfuvirtide.[corrected].
A Gudipudi, C Bajji, RR Kosana, K Panati, D Lomada, AT VR, VR Narala
Biotechnology letters 36 (9), 1761-1769, 2014
Molecular docking of glyceroneogenesis pathway intermediates with peroxisome proliferator-activated receptor-alpha (PPAR-α)
PA Subramani, K Panati, VR Narala
Bioinformation 9 (12), 629, 2013
Biochanin A Ameliorates Ovalbumin-induced Airway Inflammation through Peroxisome Proliferator-Activated Receptor-Gamma in a Mouse Model
M Derangula, K Panati, VR Narala
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021
An overview on COVID-19 pandemic: from discovery to treatment.
K Panati, VRA Tatireddygari, VR Narala
Infectious Disorders Drug Targets, 2020
Microbial production of high purity hyaluronic acid from Streptococcus zooepidemicus
JR Kanala, RS Sannidhi, K Panati, RV Narala
Bioscan 6, 601-603, 2011
The system can't perform the operation now. Try again later.
Articles 1–20